Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term OutcomesKristine Broglio, Donald A. Berry, Melanie Quintana et al.|JAMA Oncology|2016Cited by 375
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.J.J. Body, R.D. Rubens, Reiner Bartl et al.|Journal of Clinical Oncology|1998Cited by 366
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison Stopeck, Ada Braun, Karim Fizazi et al.|Supportive Care in Cancer|2015Cited by 190
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic AcidMiguel Martín, Ada Braun, Richard H. Bell et al.|Clinical Cancer Research|2012Cited by 145
P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.A. Stopeck, Ada Braun, Allan Lipton et al.|Cancer Research|2011Cited by 15